The official journal of CSACI
Articles
Page 25 of 28
-
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P32
-
Serum sickness-like reaction associated with meropenem in a 3-year old child
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P31 -
Resolution of wheat-dependent exercise induced anaphylaxis-case report
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P30 -
Prolonged elevation of serum tryptase resulting from intraoperative anaphylaxis to methylene blue
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P29 -
Case report of treatment with Icatibant for recurrent throat swelling due to hereditary angioedema
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P28 -
Adrenal suppression in an asthmatic presenting after change from high dose inhaled fluticasone propionate to inhaled budesonide
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P27 -
Reproducibility of cell counts in nasal lavage: a comparison of pooled versus non-pooled nasal lavage samples
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P26 -
The seven-transmembrane receptor, C5L2, is a stimulatory receptor on human mast cells
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P25 -
Expression and roles of glutamate (NMDA) receptors on T cell subsets
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P24 -
Expression of Semaphorin4C by Th2-stimulated B cells
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P23 -
Expression of a prostaglandin D2 receptor, CRTh2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) on human mast cells and potential relevance in allergic diseases
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P22 -
Molecular and morphological characterization of piecemeal degranulation in human neutrophil azurophilic granules
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P20 -
Redefining eosinophil crystalloid granules as a potential new functional unit in extracellular inflammatory Events
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P19 -
Prevalence of allergic sensitization to Russian thistle in Kingston and the South-eastern Ontario catchment area; a retrospective chart review
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P18 -
Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P16 -
Allergic rhinitis in the primary care setting: patient practice reflective
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P14 -
The utility of using fiberoptic endoscopy in the diagnosis of nasal polyps
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P13 -
Prevalence of mesquite (prosopis species) allergy and efficacy of conventional allergen specific Immunotherapy (ASIT) to mesquite in Egyptian patients with perennial allergic rhinitis (PAR)
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P12 -
Cockroach sensitivity in allergic rhinitis patients; is it significant? To see prevalence of cockroach sensitivity in allergic rhinitis patients in Kingston area
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P11 -
Comorbidity with depression and overweight in children with asthma
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P10 -
Results of patch testing with the textile colour and finish tray
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P9 -
Food allergy management from the perspective of patients, caregivers and allergists: a qualitative study
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P8 -
Optimizing oral immunotherapy to cow milk protein: a decision analysis
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P7 -
Flax seed allergy in children: an emerging allergen?
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P6 -
Online anaphylaxis training for schools is effective and feasible
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P5 -
Safety of H1N1 and seasonal influenza vaccines in egg allergic patients in British Columbia
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P4 -
Comparing wheat flour and commercial wheat extract skin prick testing in Wheat Dependent Exercise Induced Anaphylaxis
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P3 -
Review of food challenges in a pediatric tertiary care centre
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P2 -
Quality of penicillin allergy management in the intensive care unit and internal medicine ward
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 2):P1 -
Quantitative expression of osteopontin in nasal mucosa of patients with allergic rhinitis: effects of pollen exposure and nasal glucocorticoid treatment
Osteopontin (OPN) is a multifunctional cytokine that has been primarily investigated in Th1 diseases. Recently, it has also been implicated in Th2-mediated allergic diseases, such as asthma. The expression of ...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:28 -
Effect of allergen-specific immunotherapy with purified Alt a1 on AMP responsiveness, exhaled nitric oxide and exhaled breath condensate pH: a randomized double blind study
Little information is available on the effect of allergen-specific immunotherapy on airway responsiveness and markers in exhaled air. The aims of this study were to assess the safety of immunotherapy with puri...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:27 -
The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists
Despite over a century of clinical use and a well-documented record of efficacy and safety, a growing minority in society questions the validity of vaccination and fear that this common public health intervent...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:26 -
Eotaxin and FGF enhance signaling through an Extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is characterized by the inflammation of the esophagus and the infiltration of eosinophils into the esophagus, leading to symptoms such as dysphagia and stricture formation. Syste...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:25 -
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
We published the Canadian 2003 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema (HAE; C1 inhibitor [C1-INH] deficiency) and updated this as Hereditary angio...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:24 -
HAE therapies: past present and future
Advances in understanding the pathophysiology and mechanism of swelling in hereditary angioedema (HAE) has resulted in the development of multiple new drugs for the acute and prophylactic treatment of patients...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:23 -
HAE international home therapy consensus document
Hereditary angioedema (C1 inhibitor deficiency, HAE) is associated with intermittent swellings which are disabling and may be fatal. Effective treatments are available and these are most useful when given earl...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:22 -
On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience
Manifestation of acute edema in hereditary angioedema (HAE) is characterized by interindividual and intraindividual variability in symptom expression over time. Flexible therapy options are needed.
Citation: Allergy, Asthma & Clinical Immunology 2010 6:21 -
Management of hereditary angioedema: 2010 Canadian approach
C1-inhibitor (C1-INH) deficiency is a rare blood disorder resulting in angioedema attacks that are debilitating and may be life-threatening. Prophylaxis and therapy of events has changed since our first Canadi...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:20 -
Management of upper airway edema caused by hereditary angioedema
Hereditary angioedema is a rare disorder with a genetic background involving mutations in the genes encoding C1-INH and of factor XII. Its etiology is unknown in a proportion of cases. Recurrent edema formatio...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:19 -
Pediatric hereditary angioedema due to C1-inhibitor deficiency
Hereditary angioedema (HAE) resulting from the deficiency of the C1 inhibitor (C1-INH) is a rare, life-threatening disorder. It is characterized by attacks of angioedema involving the skin and/or the mucosa of...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:18 -
Hereditary angioedema in women
Women with hereditary angioedema (HAE) are more likely to be symptomatic that men. Hormonal factors (puberty, contraception, pregnancy,....) play a significant role in the precipitation or worsening of the con...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:17 -
Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions
The clinical, biochemical and genetic features of the conditions known as estrogen-dependent inherited angioedema, estrogen-associated angioedema, hereditary angioedema with normal C-1 inhibitor, type III angi...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:16 -
Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor
Until recently it was assumed that hereditary angioedema is a disease that results exclusively from a genetic deficiency of the C1 inhibitor. In 2000, families with hereditary angioedema, normal C1 inhibitor a...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:15 -
Acquired angioedema
Acquired angioedema (AAE) is characterized by acquired deficiency of C1 inhibitor (C1-INH), hyperactivation of the classical pathway of human complement and angioedema symptoms mediated by bradykinin released ...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:14 -
Hereditary Angioedema Consensus 2010
Citation: Allergy, Asthma & Clinical Immunology 2010 6:13 -
The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review
Primary immune deficiency disorders (PIDs) are a group of diseases associated with a genetic predisposition to recurrent infections, malignancy, autoimmunity and allergy. The molecular basis of many of these d...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:12 -
Treatment of Hereditary Angioedema: items that need to be addressed in practice parameter
Hereditary Angioedema (HAE) is a rare, autosomal dominant (AD) disorder caused by a C1 esterase inhibitor (C1-inh) deficiency or qualitative defect. Treatment of HAE in many parts of the world fall short and c...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:11 -
Rhinitis in the geriatric population
The current geriatric population in the United States accounts for approximately 12% of the total population and is projected to reach nearly 20% (71.5 million people) by 2030[1]. With this expansion of the numbe...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:10 -
Clinical experience in T cell deficient patients
T cell disorders have been poorly understood until recently. Lack of knowledge of underlying molecular mechanisms together with incomplete data on long term outcome have made it difficult to assess prognosis a...
Citation: Allergy, Asthma & Clinical Immunology 2010 6:9 -
Assessing a population-based approach to the management of respiratory disease
Citation: Allergy, Asthma & Clinical Immunology 2010 6(Suppl 1):P11
Annual Journal Metrics
-
2022 Citation Impact
2.7 - 2-year Impact Factor
3.4 - 5-year Impact Factor
0.989 - SNIP (Source Normalized Impact per Paper)
0.634 - SJR (SCImago Journal Rank)2022 Speed
17 days submission to first editorial decision for all manuscripts (Median)
133 days submission to accept (Median)2022 Usage
1,447,234 downloads
5,769 Altmetric mentions